514 Development of AIM-104, a potential best-in-class pan-allele anti-SIRPα antibody for anti-tumor therapy
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |